Histomorphometric	B:C0200760
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	O
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	B:C3178810
evaluation	O
of	O
early	O
healing	O
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	O
evaluation	B:C0220825
of	O
early	O
healing	O
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	B:C1321023
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	O
bone	I:C1321023
treated	B:C0332293
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	O
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
powder	O
.	O

Histomorphometric	O
and	O
transcriptome	O
evaluation	O
of	O
early	O
healing	O
bone	I:C1321023
treated	O
with	I:C0332293
a	O
novel	O
human	O
particulate	I:C0011429
dentin	I:C0011429
powder	B:C0032861
.	O

Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
(	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
)	O
shows	O
potential	O
as	O
an	O
alternative	O
bone	O
grafting	I:C0005976
material	O
.	O

Human	O
particulate	I:C0011429
dentin	I:C0011429
(	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
)	O
shows	O
potential	O
as	O
an	O
alternative	O
bone	O
grafting	I:C0005976
material	O
.	O

Human	O
particulate	I:C0011429
dentin	I:C0011429
(	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
)	O
shows	O
potential	O
as	O
an	O
alternative	O
bone	B:C0005976
grafting	I:C0005976
material	O
.	O

Human	O
particulate	I:C0011429
dentin	I:C0011429
(	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
)	O
shows	O
potential	O
as	O
an	O
alternative	O
bone	O
grafting	I:C0005976
material	B:C0181074
.	O

However	O
,	O
the	O
mechanism	O
of	O
bone	B:C1321023
healing	I:C1321023
at	O
the	O
molecular	O
level	O
after	O
grafting	O
with	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
is	O
unclear	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
bone	O
healing	I:C1321023
at	O
the	O
molecular	O
level	O
after	O
grafting	B:C1961139
with	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
is	O
unclear	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
bone	O
healing	I:C1321023
at	O
the	O
molecular	O
level	O
after	O
grafting	O
with	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
is	O
unclear	O
.	O

This	O
study	B:C2603343
assessed	O
the	O
histological	O
and	O
global	O
gene	O
expression	I:C0017262
of	O
bone	O
tissues	I:C0391978
grafted	O
with	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
.	O

This	O
study	O
assessed	O
the	O
histological	O
and	O
global	O
gene	B:C0017262
expression	I:C0017262
of	O
bone	O
tissues	I:C0391978
grafted	O
with	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
.	O

This	O
study	O
assessed	O
the	O
histological	O
and	O
global	O
gene	O
expression	I:C0017262
of	O
bone	B:C0391978
tissues	I:C0391978
grafted	O
with	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
.	O

This	O
study	O
assessed	O
the	O
histological	O
and	O
global	O
gene	O
expression	I:C0017262
of	O
bone	O
tissues	I:C0391978
grafted	O
with	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
.	O

The	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
was	O
prepared	O
to	O
250	O
-	O
500	O
µm	O
in	O
size	O
.	O

The	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
was	O
prepared	B:C4082130
to	O
250	O
-	O
500	O
µm	O
in	O
size	O
.	O

X	B:C0043301
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	O
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	O
structure	I:C0444626
,	O
organic	O
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	B:C0043301
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	O
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	O
structure	I:C0444626
,	O
organic	O
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	B:C2699997
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	O
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	O
structure	I:C0444626
,	O
organic	O
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	B:C2699997
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	O
structure	I:C0444626
,	O
organic	O
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	O
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	B:C0444626
structure	I:C0444626
,	O
organic	O
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
(	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
)	O
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
(	O
energy	O
dispersive	I:C2699997
x-	I:C2699997
ray	I:C2699997
spectroscopy	I:C2699997
)	O
were	O
performed	O
to	O
confirm	O
the	O
crystal	O
structure	I:C0444626
,	O
organic	B:C0029224
compound	I:C0029224
residues	O
,	O
and	O
surface	O
morphology	O
,	O
respectively	O
.	O

Bony	O
defects	O
were	O
created	O
on	O
the	O
heads	B:C0018670
of	O
24	O
New	O
Zealand	I:C0324547
White	I:C0324547
rabbits	I:C0324547
.	O

Bony	O
defects	O
were	O
created	O
on	O
the	O
heads	O
of	O
24	O
New	B:C0324547
Zealand	I:C0324547
White	I:C0324547
rabbits	I:C0324547
.	O

Sterilized	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
was	O
used	O
as	O
the	O
grafting	O
material	I:C0181074
.	O

Sterilized	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
was	O
used	O
as	O
the	O
grafting	B:C0181074
material	I:C0181074
.	O

The	O
quality	O
and	O
quantity	O
of	O
new	B:C0029433
bone	I:C0029433
formation	I:C0029433
was	O
evaluated	O
using	O
micro-CT	O
and	O
histologic	O
analyses	O
during	O
the	O
8	O
week	O
experimental	O
periods	O
.	O

The	O
quality	O
and	O
quantity	O
of	O
new	O
bone	I:C0029433
formation	I:C0029433
was	O
evaluated	B:C0220825
using	O
micro-CT	O
and	O
histologic	O
analyses	O
during	O
the	O
8	O
week	O
experimental	O
periods	O
.	O

The	O
quality	O
and	O
quantity	O
of	O
new	O
bone	I:C0029433
formation	I:C0029433
was	O
evaluated	O
using	O
micro-CT	B:C2350281
and	O
histologic	O
analyses	O
during	O
the	O
8	O
week	O
experimental	O
periods	O
.	O

The	O
quality	O
and	O
quantity	O
of	O
new	O
bone	I:C0029433
formation	I:C0029433
was	O
evaluated	O
using	O
micro-CT	O
and	O
histologic	O
analyses	B:C0936012
during	O
the	O
8	O
week	O
experimental	O
periods	O
.	O

For	O
microarray	B:C0022885
assay	I:C0022885
,	O
bone	O
tissue	I:C0391978
and	O
blood	O
samples	I:C0178913
were	O
taken	O
at	O
3	O
,	O
5	O
and	O
7	O
d	O
post-	O
implantation	O
.	O

For	O
microarray	O
assay	I:C0022885
,	O
bone	B:C0391978
tissue	I:C0391978
and	O
blood	O
samples	I:C0178913
were	O
taken	O
at	O
3	O
,	O
5	O
and	O
7	O
d	O
post-	O
implantation	O
.	O

For	O
microarray	O
assay	I:C0022885
,	O
bone	O
tissue	I:C0391978
and	O
blood	B:C0178913
samples	I:C0178913
were	O
taken	O
at	O
3	O
,	O
5	O
and	O
7	O
d	O
post-	O
implantation	O
.	O

The	O
results	B:C0456984
of	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
showed	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	O
.	O

The	O
results	O
of	O
X	B:C0043301
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
showed	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	O
.	O

The	O
results	O
of	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
energy	B:C2699997
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
showed	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	O
.	O

The	O
results	O
of	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
showed	O
that	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	O
.	O

The	O
results	O
of	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
energy	O
dispersive	I:C2699997
x-ray	I:C2699997
spectroscopy	I:C2699997
showed	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
exhibited	O
physical	O
and	O
chemical	O
properties	O
similar	O
to	O
natural	O
hydroxyapatite	B:C0020326
.	O

New	B:C0029433
bone	I:C0029433
formation	I:C0029433
was	O
observed	O
after	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
implantation	O
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
and	O
micro-CT	O
.	O

New	O
bone	I:C0029433
formation	I:C0029433
was	O
observed	O
after	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
implantation	O
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
and	O
micro-CT	O
.	O

New	O
bone	I:C0029433
formation	I:C0029433
was	O
observed	O
after	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
implantation	B:C0021107
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
and	O
micro-CT	O
.	O

New	O
bone	I:C0029433
formation	I:C0029433
was	O
observed	O
after	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
implantation	O
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	B:C0523207
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
and	O
micro-CT	O
.	O

New	O
bone	I:C0029433
formation	I:C0029433
was	O
observed	O
after	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
implantation	O
compared	O
to	O
the	O
controls	O
,	O
as	O
shown	O
on	O
hematoxylin	O
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
and	O
micro-CT	B:C2350281
.	O

The	O
bone	O
volume	O
of	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
treated	O
animals	O
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
at	O
all	O
observation	O
times	O
.	O

The	O
bone	O
volume	O
of	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
treated	O
animals	B:C0003062
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
at	O
all	O
observation	O
times	O
.	O

The	O
bone	O
volume	O
of	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
treated	O
animals	O
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
at	O
all	O
observation	B:C0302523
times	O
.	O

Microarray	B:C1449575
analysis	I:C1449575
showed	O
that	O
vascular	O
development	I:C1621270
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	O
were	O
expressed	O
in	O
the	O
early	O
healing	O
stage	O
.	O

Microarray	O
analysis	I:C1449575
showed	O
that	O
vascular	B:C1621270
development	I:C1621270
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	O
were	O
expressed	O
in	O
the	O
early	O
healing	O
stage	O
.	O

Microarray	O
analysis	I:C1449575
showed	O
that	O
vascular	O
development	I:C1621270
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	B:C0017337
were	O
expressed	O
in	O
the	O
early	O
healing	O
stage	O
.	O

Microarray	O
analysis	I:C1449575
showed	O
that	O
vascular	O
development	I:C1621270
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	O
were	O
expressed	B:C0017262
in	O
the	O
early	O
healing	O
stage	O
.	O

Microarray	O
analysis	I:C1449575
showed	O
that	O
vascular	O
development	I:C1621270
coupled	O
with	O
immune	O
and	O
inflammatory	O
related	O
genes	O
were	O
expressed	O
in	O
the	O
early	O
healing	B:C0043240
stage	O
.	O

The	O
gene	B:C3839127
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	B:C3536785
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	B:C1416402
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	B:C0017262
to	O
inhibit	O
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	O
to	O
inhibit	B:C0021469
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	B:C1155266
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	O
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

The	O
gene	O
coding	I:C3839127
for	O
the	O
IL	O
-	I:C3536785
1	I:C3536785
antagonist	I:C3536785
,	O
IL1RN	O
,	O
was	O
expressed	O
to	O
inhibit	O
the	O
inflammatory	O
response	I:C1155266
,	O
and	O
at	O
the	O
same	O
time	O
,	O
the	O
CCL2	B:C1337092
gene	I:C1337092
was	O
activated	O
to	O
2.3	O
times	O
the	O
normal	O
level	O
.	O

BMP2	B:C1332424
,	O
RUNX2	O
,	O
COL1A	O
,	O
and	O
OPN	O
expression	O
were	O
also	O
up	O
-	I:C0041904
regulated	I:C0041904
.	O

BMP2	O
,	O
RUNX2	B:C1419771
,	O
COL1A	O
,	O
and	O
OPN	O
expression	O
were	O
also	O
up	O
-	I:C0041904
regulated	I:C0041904
.	O

BMP2	O
,	O
RUNX2	O
,	O
COL1A	B:C0017337
,	O
and	O
OPN	O
expression	O
were	O
also	O
up	O
-	I:C0041904
regulated	I:C0041904
.	O

BMP2	O
,	O
RUNX2	O
,	O
COL1A	O
,	O
and	O
OPN	B:C1420369
expression	O
were	O
also	O
up	O
-	I:C0041904
regulated	I:C0041904
.	O

BMP2	O
,	O
RUNX2	O
,	O
COL1A	O
,	O
and	O
OPN	O
expression	B:C0017262
were	O
also	O
up	O
-	I:C0041904
regulated	I:C0041904
.	O

BMP2	O
,	O
RUNX2	O
,	O
COL1A	O
,	O
and	O
OPN	O
expression	O
were	O
also	O
up	B:C0041904
-	I:C0041904
regulated	I:C0041904
.	O

CCL2	B:C1337092
predominated	O
in	O
osteoblastogenesis	O
of	O
the	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
-	O
treated	O
bony	O
defect	O
in	O
the	O
early	O
stage	O
of	O
healing	O
.	O

CCL2	O
predominated	O
in	O
osteoblastogenesis	B:C1159974
of	O
the	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
-	O
treated	O
bony	O
defect	O
in	O
the	O
early	O
stage	O
of	O
healing	O
.	O

CCL2	O
predominated	O
in	O
osteoblastogenesis	O
of	O
the	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
-	O
treated	O
bony	O
defect	O
in	O
the	O
early	O
stage	O
of	O
healing	O
.	O

CCL2	O
predominated	O
in	O
osteoblastogenesis	O
of	O
the	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
-	O
treated	O
bony	O
defect	O
in	O
the	O
early	O
stage	O
of	O
healing	B:C0043240
.	O

Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
accelerated	O
bone	O
regeneration	I:C0005972
and	O
augmentation	O
.	O

Human	O
particulate	I:C0011429
dentin	I:C0011429
accelerated	O
bone	B:C0005972
regeneration	I:C0005972
and	O
augmentation	O
.	O

Human	O
particulate	I:C0011429
dentin	I:C0011429
accelerated	O
bone	O
regeneration	I:C0005972
and	O
augmentation	B:C0332509
.	O

These	O
results	B:C0456984
suggested	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
provided	O
potential	O
as	O
a	O
bone	O
graft	I:C0005976
resource	O
during	O
the	O
bone	O
healing	O
process	I:C2004454
.	O

These	O
results	O
suggested	O
that	O
Human	B:C0011429
particulate	I:C0011429
dentin	I:C0011429
provided	O
potential	O
as	O
a	O
bone	O
graft	I:C0005976
resource	O
during	O
the	O
bone	O
healing	O
process	I:C2004454
.	O

These	O
results	O
suggested	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
provided	O
potential	O
as	O
a	O
bone	B:C0005976
graft	I:C0005976
resource	O
during	O
the	O
bone	O
healing	O
process	I:C2004454
.	O

These	O
results	O
suggested	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
provided	O
potential	O
as	O
a	O
bone	O
graft	I:C0005976
resource	O
during	O
the	O
bone	B:C0262950
healing	O
process	I:C2004454
.	O

These	O
results	O
suggested	O
that	O
Human	O
particulate	I:C0011429
dentin	I:C0011429
provided	O
potential	O
as	O
a	O
bone	O
graft	I:C0005976
resource	O
during	O
the	O
bone	O
healing	B:C2004454
process	I:C2004454
.	O

